Virtual coronary stenting from coronary computed tomographic angiography (CTA)-derived imaging is feasible and may aid in planning optimal invasive strategies and predicting functional outcome, ...
Extensive clinical and real-world validation: Heartflow’s AI-driven solutions have been validated through clinical evidence in over 100 studies assessing over 365,000 patients. Proven in real-world ...
Please provide your email address to receive an email when new articles are posted on . For the TARGET trial, presented at the American College of Cardiology Scientific Session and simultaneously ...
NEW ORLEANS, LA — Entry to a large randomized clinical-outcomes trial was stopped early after its data and safety monitoring board (DSMB) saw a significant jump in early mortality in patients ...
Current practice for evaluating patients with stable chest pain often requires noninvasive or invasive testing. 3,4 Coronary computed tomographic angiography (CTA) is a noninvasive anatomical test for ...
Correction: This story has been updated to reflect the number of PCI procedures that use FFR measurements. It is 20%, or "one in five," and not five out of 900,000 as previously stated. St. Jude ...
Physiological assessment with fractional flow reserve (FFR) is no better than angiography when it comes to guiding complete revascularization in STEMI patients with multivessel disease who’ve ...
AGREEMENT ALLOWS CARDIOLOGISTS TO PERFORM DPR AND FFR PROCEDURES USING OPSENS' OPTOWIRE AND CATHMEDICAL'S PICASSO SYSTEM IN AN INTEGRATED FASHION QUEBEC CITY, April 21, 2021 /CNW/ - OpSens Inc.
Eindhoven, the Netherlands - To PTCA or not to PTCA? That is often the question in patients with angiographically evident coronary stenosis and chest pain, but no clear-cut evidence of reversible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback